FBIOX vs. FNCMX
Compare and contrast key facts about Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity NASDAQ Composite Index Fund (FNCMX).
FBIOX is managed by Fidelity. It was launched on Dec 16, 1985. FNCMX is managed by Fidelity.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBIOX or FNCMX.
Key characteristics
| FBIOX | FNCMX | |
|---|---|---|
| YTD Return | 24.03% | 29.27% |
| 1Y Return | 54.48% | 40.81% |
| 3Y Return (Ann) | 0.56% | 7.86% |
| 5Y Return (Ann) | 1.73% | 18.11% |
| 10Y Return (Ann) | 1.72% | 15.64% |
| Sharpe Ratio | 2.68 | 2.49 |
| Sortino Ratio | 3.61 | 3.19 |
| Omega Ratio | 1.43 | 1.44 |
| Calmar Ratio | 1.07 | 3.33 |
| Martin Ratio | 11.67 | 12.54 |
| Ulcer Index | 4.71% | 3.49% |
| Daily Std Dev | 20.56% | 17.52% |
| Max Drawdown | -71.96% | -55.71% |
| Current Drawdown | -25.07% | 0.00% |
Correlation
The correlation between FBIOX and FNCMX is 0.70, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
FBIOX vs. FNCMX - Performance Comparison
In the year-to-date period, FBIOX achieves a 24.03% return, which is significantly lower than FNCMX's 29.27% return. Over the past 10 years, FBIOX has underperformed FNCMX with an annualized return of 1.72%, while FNCMX has yielded a comparatively higher 15.64% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBIOX vs. FNCMX - Expense Ratio Comparison
FBIOX has a 0.69% expense ratio, which is higher than FNCMX's 0.29% expense ratio.
Risk-Adjusted Performance
FBIOX vs. FNCMX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity NASDAQ Composite Index Fund (FNCMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBIOX vs. FNCMX - Dividend Comparison
FBIOX's dividend yield for the trailing twelve months is around 0.65%, more than FNCMX's 0.52% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 0.65% | 0.45% | 0.00% | 0.17% | 0.26% | 0.15% | 0.00% | 0.00% | 0.00% | 6.71% | 10.77% | 0.25% |
FNCMX Fidelity NASDAQ Composite Index Fund | 0.52% | 0.67% | 0.88% | 0.47% | 0.67% | 0.97% | 0.94% | 0.70% | 0.91% | 0.89% | 0.80% | 0.72% |
Drawdowns
FBIOX vs. FNCMX - Drawdown Comparison
The maximum FBIOX drawdown since its inception was -71.96%, which is greater than FNCMX's maximum drawdown of -55.71%. Use the drawdown chart below to compare losses from any high point for FBIOX and FNCMX. For additional features, visit the drawdowns tool.
Volatility
FBIOX vs. FNCMX - Volatility Comparison
The current volatility for Fidelity Select Biotechnology Portfolio (FBIOX) is 4.58%, while Fidelity NASDAQ Composite Index Fund (FNCMX) has a volatility of 5.32%. This indicates that FBIOX experiences smaller price fluctuations and is considered to be less risky than FNCMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.